Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
The study will investigate efficacy of STW5-II as add-on therapy on the rate to remission in patients with mild to moderate ulcerative colitis in an acute flare.
Epistemonikos ID: 53b770763506fa0d04270999db9f8211db587a6d
First added on: Mar 23, 2022